Algernon Receives Regulatory and Ethics Approval for Phase 2 Ifenprodil COVID-19 Human Study in South Korea Pharmaceutical Investing
Codebase Investment Adds Oral Mucosal Patent Filing, Expanding Transdermal Treatments Pharmaceutical Investing
Algernon Submits Application to Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial Pharmaceutical Investing
BioHarvest Sciences Inc. (formerly, Canna-V-Cell Sciences Inc.) Closes Agreement and Plan of Merger and announces the Results of its Annual General Meeting and Special Meeting Cannabis Investing News
Lions Bay Mining Announces Non-Binding LOI to Acquire BioVaxys LLC, a Clinical Stage Biopharma Company Developing Immunotherapeutic Vaccines for Life-threatening Viral Infections and Cancers Biotech Investing
Revive Therapeutics Announces Research Partnership Agreement with the University of Wisconsin-Madison Pharmaceutical Investing
BriaCell Files New Provisional Patent Application for Antibody-Based Treatment of Infectious Diseases Biotech Investing
Lexaria Bioscience Files New Patent Utilizing DehydraTECH Technology for Treatment of Infectious Diseases Including COVID-19 Biotech Investing
Hydroxychloroquine Side Effects Potentially Mitigated by Transdermal Delivery Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
